Royce & Associates’s Avadel Pharmaceuticals AVDL Stock Holding History

Royce & Associates’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$278K	Hold
2024 Q4	$373K	Hold
2024 Q3	$465K	Hold
2024 Q2	$499K	Sell
2024 Q1	$820K	Buy
2023 Q4	$296K	Buy